aldosterone has been researched along with Aortic Diseases in 12 studies
Aortic Diseases: Pathological processes involving any part of the AORTA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Increased endothelin-1 (ET-1) or aldosterone may be associated with promotion of cardiovascular hypertrophy and fibrosis." | 7.71 | Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1. ( Park, JB; Schiffrin, EL, 2002) |
| "To study the effects of Ca antagonists on hypertension induced cardiac and vascular hypertrophy, diltiazem, at the doses of 30 and 60 mg/kg, p." | 7.67 | [Effects of diltiazem on developing blood pressure and accompanying cardiac and vascular hypertrophy in SHR]. ( Inamasu, M; Iwasaki, HO; Morita, T; Nagao, T; Narita, H, 1985) |
| "Allisartan isoproxil (ALL) is a new angiotensin II receptor blocker and a new antihypertensive drug discovered and developed in China." | 5.62 | Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage. ( Cheng, MH; Fu, FH; Ling, QS; Liu, AJ; Liu, JG; Miao, CY; Tian, JS; Zhang, SL, 2021) |
| "Primary aldosteronism (PA) is associated with a higher prevalence of abdominal aortic calcification (AAC)." | 5.56 | Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels. ( Li, N; Luo, Q; Tuersun, T; Wang, G; Wang, M; Wu, T; Yue, N; Zhang, D; Zhang, Z; Zhou, K, 2020) |
| "Aldosterone treatment increased lipid content of plaques (2." | 5.39 | Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism. ( Armani, A; Bagley, J; Caprio, M; Carmeliet, P; Chen, WS; Galayda, C; Jaffe, IZ; McGraw, AP; Nickerson, H, 2013) |
| "Increased endothelin-1 (ET-1) or aldosterone may be associated with promotion of cardiovascular hypertrophy and fibrosis." | 3.71 | Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1. ( Park, JB; Schiffrin, EL, 2002) |
| "To study the effects of Ca antagonists on hypertension induced cardiac and vascular hypertrophy, diltiazem, at the doses of 30 and 60 mg/kg, p." | 3.67 | [Effects of diltiazem on developing blood pressure and accompanying cardiac and vascular hypertrophy in SHR]. ( Inamasu, M; Iwasaki, HO; Morita, T; Nagao, T; Narita, H, 1985) |
| "Primary aldosteronism (PA) is the most common cause of secondary hypertension." | 2.82 | Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects. ( Bioletto, F; Bollati, M; Ghigo, E; Lopez, C; Maccario, M; Parasiliti-Caprino, M; Ponzetto, F, 2022) |
| "Allisartan isoproxil (ALL) is a new angiotensin II receptor blocker and a new antihypertensive drug discovered and developed in China." | 1.62 | Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage. ( Cheng, MH; Fu, FH; Ling, QS; Liu, AJ; Liu, JG; Miao, CY; Tian, JS; Zhang, SL, 2021) |
| "Primary aldosteronism (PA) is associated with a higher prevalence of abdominal aortic calcification (AAC)." | 1.56 | Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels. ( Li, N; Luo, Q; Tuersun, T; Wang, G; Wang, M; Wu, T; Yue, N; Zhang, D; Zhang, Z; Zhou, K, 2020) |
| "Aldosterone treatment increased lipid content of plaques (2." | 1.39 | Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism. ( Armani, A; Bagley, J; Caprio, M; Carmeliet, P; Chen, WS; Galayda, C; Jaffe, IZ; McGraw, AP; Nickerson, H, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bollati, M | 1 |
| Lopez, C | 1 |
| Bioletto, F | 1 |
| Ponzetto, F | 1 |
| Ghigo, E | 1 |
| Maccario, M | 1 |
| Parasiliti-Caprino, M | 1 |
| Pu, Y | 1 |
| Yang, G | 1 |
| Pan, X | 1 |
| Zhou, Y | 1 |
| Zhong, A | 1 |
| Ding, N | 1 |
| Su, Y | 1 |
| Peng, W | 1 |
| Zeng, M | 1 |
| Guo, T | 1 |
| Chai, X | 1 |
| Tuersun, T | 1 |
| Luo, Q | 1 |
| Zhang, Z | 1 |
| Wang, G | 1 |
| Zhang, D | 1 |
| Wang, M | 1 |
| Wu, T | 1 |
| Zhou, K | 1 |
| Yue, N | 1 |
| Li, N | 1 |
| Ling, QS | 1 |
| Zhang, SL | 1 |
| Tian, JS | 1 |
| Cheng, MH | 1 |
| Liu, AJ | 1 |
| Fu, FH | 1 |
| Liu, JG | 1 |
| Miao, CY | 1 |
| McGraw, AP | 1 |
| Bagley, J | 1 |
| Chen, WS | 1 |
| Galayda, C | 1 |
| Nickerson, H | 1 |
| Armani, A | 1 |
| Caprio, M | 1 |
| Carmeliet, P | 1 |
| Jaffe, IZ | 1 |
| Keidar, S | 1 |
| Kaplan, M | 1 |
| Pavlotzky, E | 1 |
| Coleman, R | 1 |
| Hayek, T | 1 |
| Hamoud, S | 1 |
| Aviram, M | 1 |
| Kirkendall, WM | 1 |
| Overturf, ML | 1 |
| Druilhet, RE | 1 |
| Wexler, BC | 1 |
| Iams, SG | 1 |
| de Lasson, L | 1 |
| Hansen, HE | 1 |
| Juhl, B | 1 |
| Paaske, WP | 1 |
| Pedersen, EB | 1 |
| Park, JB | 1 |
| Schiffrin, EL | 1 |
| Davis, JO | 1 |
| Freeman, RH | 1 |
| Narita, H | 1 |
| Nagao, T | 1 |
| Inamasu, M | 1 |
| Iwasaki, HO | 1 |
| Morita, T | 1 |
2 reviews available for aldosterone and Aortic Diseases
| Article | Year |
|---|---|
Atrial Fibrillation and Aortic Ectasia as Complications of Primary Aldosteronism: Focus on Pathophysiological Aspects.
Topics: Aldosterone; Animals; Aorta; Aortic Diseases; Atrial Fibrillation; Humans; Hyperaldosteronism | 2022 |
Mechanisms regulating renin release.
Topics: Aldosterone; Angiotensin II; Animals; Aortic Diseases; Blood Pressure; Brain; Calcium; Catecholamine | 1976 |
1 trial available for aldosterone and Aortic Diseases
| Article | Year |
|---|---|
A randomised, clinical study of the effect of low-dose dopamine on central and renal haemodynamics in infrarenal aortic surgery.
Topics: Aged; Aldosterone; Angiotensin II; Aorta, Abdominal; Aortic Diseases; Arginine Vasopressin; Arterios | 1995 |
9 other studies available for aldosterone and Aortic Diseases
| Article | Year |
|---|---|
Higher plasma aldosterone concentrations in patients with aortic diseases and hypertension: a retrospective observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Aortic Diseases; Blood Pressure; Female; Hu | 2023 |
Abdominal aortic calcification is more severe in unilateral primary aldosteronism patients and is associated with elevated aldosterone and parathyroid hormone levels.
Topics: Adult; Aldosterone; Aortic Diseases; China; Cross-Sectional Studies; Female; Humans; Hyperaldosteron | 2020 |
Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Aorti | 2021 |
Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism.
Topics: Aldosterone; Animals; Aorta, Abdominal; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Chemoki | 2013 |
Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
Topics: Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme | 2004 |
Is renin a risk factor?
Topics: Aldosterone; Animals; Aortic Diseases; Arteriosclerosis; Cholesterol, Dietary; Diet, Atherogenic; Hy | 1981 |
Changes in the morphology and location of arterial lesions in virgin and breeder Sprague-Dawley and spontaneously hypertensive rats (SHR) to adrenal regeneration hypertension.
Topics: Adrenal Glands; Aldosterone; Animals; Aorta; Aortic Diseases; Arterioles; Arteriosclerosis; Blood Pr | 1980 |
Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1.
Topics: Aldosterone; Animals; Antihypertensive Agents; Aorta; Aortic Diseases; Blood Pressure; Body Weight; | 2002 |
[Effects of diltiazem on developing blood pressure and accompanying cardiac and vascular hypertrophy in SHR].
Topics: Aldosterone; Animals; Aorta; Aortic Diseases; Benzazepines; Cardiomegaly; Diltiazem; Hindlimb; Hyper | 1985 |